Safinamide
Back to searchMolecule Structure
Scientific Name
Safinamide
Description of the Drug
Safinamide is a MAO-B inhibitor used as an add-on treatment to levodopa/carbidopa for Parkinson’s disease during “off” episodes.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06654
http://www.drugbank.ca/drugs/DB06654
Brand Name(s)
Xadago
Company Owner(s)
Mdd Us Operations Llc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Monoamine oxidase B | SINGLE PROTEIN | INHIBITOR | CHEMBL2039 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL69350 | ||
DrugBank | DB06654 | ||
PubChem: Thomson Pharma | 14825333 | 14849630 | |
PubChem | 131682 | ||
LINCS | LSM-45956 | ||
Nikkaji | J621.455J | ||
BindingDB | 50078694 | 19187 | |
DrugCentral | 4921 | ||
Brenda | 163192 | 7740 | |
ChemicalBook | CB71011620 | ||
Guide to Pharmacology | 8291 | ||
rxnorm | XADAGO | SAFINAMIDE | SAFINAMIDE MESYLATE |
ChEBI | 134718 | ||
ZINC | ZINC000053084692 |